Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

NCT03640325 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT03640325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
Lead sponsor
Seattle Children's Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2019
Completion date
March 31, 2024
Enrollment
143 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, adolescent behavior, anxiety, bone marrow neoplasms, cancer, coping skills, depression, quality of life